Caprolactam Chemicals Limited posted a full-year net profit of ₹176.12 lakh for FY26, reversing a loss of ₹70.87 lakh recorded in the corresponding period of the previous year. The company’s revenue from operations more than doubled to ₹1,055.75 lakh, up from ₹673.96 lakh in FY25.

The 37th Annual General Meeting (AGM) is scheduled for September 28, 2026, to adopt the audited financial statements and approve key corporate actions. Shareholders holding shares as on the record date of September 21, 2026, will be eligible to vote via remote e-voting between September 24 and September 27, 2026.

Financial Performance

The company’s total income rose to ₹1,058.86 lakh from ₹674.92 lakh in the prior year. This growth was primarily driven by a surge in sale of services, which reached ₹1,028.69 lakh compared to ₹606.42 lakh previously. Sales of manufactured goods declined to ₹27.06 lakh from ₹67.54 lakh.

Total expenses increased to ₹842.29 lakh from ₹743.29 lakh. Finance costs rose to ₹71.91 lakh from ₹63.24 lakh, while depreciation and amortisation expenses decreased slightly to ₹161.41 lakh from ₹165.04 lakh. The company incurred a total tax expense of ₹40.44 lakh, comprising current tax of ₹37.35 lakh and deferred tax of ₹3.09 lakh.

Balance Sheet and Cash Flow

As of March 31, 2026, total assets stood at ₹1,703.96 lakh, up from ₹1,428.42 lakh. Current assets increased significantly to ₹657.13 lakh, driven by a rise in trade receivables to ₹621.18 lakh from ₹282.42 lakh. Inventories declined to ₹16.26 lakh from ₹40.65 lakh.

Short-term borrowings rose to ₹922.90 lakh from ₹871.34 lakh. The company maintained cash and cash equivalents of ₹8.69 lakh. Net cash generated from operating activities was ₹164.97 lakh, compared to an outflow of ₹56.18 lakh in the previous year.

Corporate Actions

The Board recommended the reappointment of Mrs. Zaver Shankarlal Bhanushali as Managing Director, who retires by rotation. Additionally, shareholders will vote to appoint M/s. Raman S. Shah & Co. as statutory auditors for a five-year term commencing from the conclusion of the AGM.

No dividend has been declared for FY26. The company’s paid-up equity share capital remains unchanged at ₹460 lakh, comprising 46 lakh equity shares of ₹10 each.

Caprolactam Chemicals Limited has recommended the appointment of M/s. Raman S. Shah & Co as its statutory auditors. The Board of Directors approved the proposal during a meeting held on August 31, 2026.

The recommendation follows advice from the Audit Committee, which cited the firm’s professional expertise and suitability for the company’s audit requirements. The proposed engagement is subject to shareholder approval at the ensuing Annual General Meeting (AGM).

Auditor Details

The firm, bearing Registration No. 111919W, is led by signing partner Raman S. Shah (Membership No. 033272). The proposed audit fees are set at ₹110000 plus applicable taxes and reimbursement of out-of-pocket expenses.

The appointment requires receipt of requisite consent and eligibility certificates confirming compliance with the Companies Act, 2013. The firm has no relationship with the company’s directors or key managerial personnel.

AGM Logistics

The board also approved logistical arrangements for the 37th AGM, scheduled for September 28, 2026, at 10:30 am. Purva Sharegistry (India) Pvt. Ltd. has been appointed to handle e-voting services.

Mr. Rahul Shivji Gori was appointed as the scrutinizer for the e-voting process. The record date for determining voting eligibility is September 21, 2026. Shareholders may cast votes electronically from 9:00 am on Thursday, September 24, 2026, to 5:00 pm on Sunday, September 27, 2026.